Enlight Announces Participation at Upcoming JP Morgan and Roth MKM Investor Conferences
TEL AVIV, Israel, May 20, 2024 (GLOBE NEWSWIRE) — Enlight Renewable Energy (“Enlight”) (NASDAQ: ENLT, TASE: ENLT), a leading global […]
Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference
BOCA RATON, Fla., May 20, 2024 (GLOBE NEWSWIRE) — Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a […]
Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale
New production process will be developed based on Pluri’s proprietary 3D cell expansion technology Human breast milk oligosaccharides are known […]
Vivid Seats to Participate in William Blair’s 2024 Growth Stock Conference
CHICAGO, May 20, 2024 (GLOBE NEWSWIRE) — Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats”), a leading marketplace that utilizes its […]
ECARX Announces First Quarter 2024 Unaudited Financial Results
Exhibit 99.1 SHANGHAI, China, May 20, 2024 (GLOBE NEWSWIRE) — ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a […]
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel
SHENZHEN, China, May 20, 2024 (GLOBE NEWSWIRE) — Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), […]
ANI Pharmaceuticals Announces the Launch of Kionex® Suspension
BAUDETTE, Minn., May 20, 2024 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the […]
Public Entities of America, LLC joins Apex Insurance Agency, LLC, part of Bridge Specialty Group, LLC
DAYTONA BEACH, Fla., May 20, 2024 (GLOBE NEWSWIRE) — Bridge Specialty Group, LLC (“Bridge Specialty”) is very pleased to welcome […]
Scorpio Tankers Inc. Announces Agreement for a $223.6 Million Prepayment under its 2023 $1.0 Billion Credit Facility
MONACO, May 20, 2024 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE:STNG) (“Scorpio Tankers,” or the “Company”) announced today that it […]
Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints
– In Phase 1/2 ACHIEVE Trial, DYNE-101 Demonstrated Dose Dependent 27% Mean Splicing Correction Across All Patients in the 5.4 […]
